BOSTON & LONDON--(BUSINESS WIRE)--Signifier Medical Technologies Ltd, a pioneer in patient-friendly therapies for sleep disordered breathing, announced that it has successfully raised $35 million in ...

Signifier Medical Technologies, an innovator in the sleep disordered breathing market, today announced that eXciteOSA ®, the first and only daytime intraoral neuromuscular stimulation device for ...

The eXciteOSA device is used while the individual is awake and provides electrical muscle stimulation through a mouthpiece that sits around the tongue. The Food and Drug Administration (FDA) has ...

BOSTON & LONDON — Signifier Medical Technologies LLC (“Signifier” or the “Company”), a Boston-based medical technology company, announces the FDA approval to remove dental contraindications for ...

BOSTON--(BUSINESS WIRE)--Signifier Medical Technologies LLC (“Signifier” or the “Company”), a Boston-based medical technology company, announced that Waha ...

BOSTON — Signifier Medical Technologies Limited (“Signifier” and the “Company”), a leader in medical technologies specializing in sleep apnea therapy solutions, is thrilled to announce its largest ...

Signifier Medical Technologies Limited (“Signifier”), a global leader in medical technology for sleep-disordered breathing, announces that it has achieved the EU MDR certification for eXciteOSA®, its ...

Signifier Medical Technologies Limited ("Signifier"), a global leader in medical technology for sleep-disordered breathing, announced today that eXciteOSA, its non-invasive daytime therapy for ...

Signifier Medical Technologies Ltd, a pioneer in patient-friendly therapies for sleep disordered breathing, announced that it has successfully raised $35 million in its Series D capital raise. This ...